MyFinsight
Home
Blog
About
Back
Income Statement
Atrium Therapeutics, Inc. (RNA)
Atrium Therapeutics, Inc. (RNA)
source: myfinsight.com
Comprehensive loss
-$20,421K
(87.10%↑ Y/Y)
Interest income
$2,104K
(-85.47%↓ Y/Y)
Other income
(expense), net
$328K
(150.38%↑ Y/Y)
Net loss
-$20,186K
(87.17%↑ Y/Y)
Net unrealized gain
on short-term...
-$235K
(78.32%↑ Y/Y)
Total other income
(expense)
$2,432K
(-82.41%↓ Y/Y)
Loss from operations
-$22,618K
(86.78%↑ Y/Y)
Collaboration revenue
$3,004K
(-21.91%↓ Y/Y)
Total operating
expenses
$25,622K
(-85.36%↓ Y/Y)
Research and development
$15,343K
(-88.89%↓ Y/Y)
General and
administrative
$10,279K
(-72.12%↓ Y/Y)
Back